MetaCap

AnaptysBio (ANAB) vs Phibro Animal Health (PAHC)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

AnaptysBio (ANAB) has outperformed Phibro Animal Health (PAHC) over the past year, gaining 76.6% versus a loss of 20.0%. Over five years, ANAB leads with a +124.8% price change compared with +59.4% for PAHC. AnaptysBio is the larger company by market cap ($1.39 billion vs $1.35 billion), about 1.0 times the size.

On valuation, Phibro Animal Health trades at a lower forward P/E (8.6x vs 8.7x for AnaptysBio). Phibro Animal Health pays a dividend yielding 1.44%, while AnaptysBio does not currently pay one. Phibro Animal Health converts more of its revenue into profit, with a net margin of 6.6% versus -5.6%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ANAB+76.58%PAHC-20.03%
+174%+66%-41%
Nov 21, 20251 yearNov 20, 2026
ANAB+127.09%PAHC+52.78%
+252%+90%-72%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ANAB versus PAHC key metrics
MetricANABPAHC
Share price$46.63$33.29
Market cap$1.39B$1.35B
1-day change-1.62%-2.32%
YTD return+44.28%-10.89%
1-year return+76.58%-20.03%
5-year return+124.76%+59.43%
P/E ratio (TTM)7.1513.26
Forward P/E8.668.58
EPS (TTM)$6.52$2.51
Dividend yield0.00%1.44%
Annual dividend$0.00$0.48
Revenue (latest FY)$234.60M$1.52B
Revenue growth (YoY)+157.01%+17.12%
Net income (latest FY)$-13.23M$99.72M
Gross margin—33.76%
Operating margin96.72%12.81%
Net margin-5.64%6.57%
52-week high$72.36$60.08
52-week low$26.01$28.25
Distance from 52-week high-35.56%-44.59%
Analyst consensusstrong_buyhold
Avg. price target upside+87.11%+41.18%
Average volume496.92K228.99K
Shares outstanding29.73M21.11M
Employees—2,605
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • ANAB has outperformed PAHC by 96.6 percentage points over the past year.
  • Phibro Animal Health trades at a higher earnings multiple (13.3x vs 7.2x trailing P/E).
  • Phibro Animal Health offers a meaningfully higher dividend yield (1.44% vs 0.00%).
  • Phibro Animal Health is more profitable, keeping 6.6 cents of every revenue dollar as net income versus -5.6 cents for AnaptysBio.
  • AnaptysBio grew revenue faster in its latest fiscal year (+157.01% vs +17.12%).

About AnaptysBio

ANAB stock →

AnaptysBio, Inc. discovers and out-licenses therapeutic bodies in the United States.

Health Care · Biotechnology: Pharmaceutical Preparations

About Phibro Animal Health

PAHC stock →

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products.

Health Care · Biotechnology: Pharmaceutical Preparations · 2,605 employees

ANAB vs PAHC FAQ

Which is bigger, AnaptysBio or Phibro Animal Health?

AnaptysBio (ANAB) is larger, with a market capitalization of $1.39B compared with $1.35B for Phibro Animal Health (PAHC).

Which stock has performed better over the past year, ANAB or PAHC?

ANAB returned +76.58% over the past 12 months, compared with -20.03% for PAHC (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, ANAB or PAHC?

ANAB has the lower trailing P/E at 7.2, versus 13.3 for PAHC. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Which pays a higher dividend, AnaptysBio or Phibro Animal Health?

Phibro Animal Health pays a dividend yielding 1.44%, while AnaptysBio does not currently pay a regular dividend.

Are AnaptysBio and Phibro Animal Health in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons